Efforts to boost diversity and inclusion at life science organizations are themselves becoming more diverse. A growing number of biotech companies are adjusting their recruitment and hiring practices to ensure that... Read more »
Less than one month after emerging from stealth, ag biotech startup Inari Agriculture is unveiling $40 million in capital to accelerate its work on gene-editing for crop breeding.
The Series B... Read more »
Hearing loss for many people is hereditary—a mutation in a single gene impairs hearing from birth. There are no approved drugs for this type of hearing loss, but biotech startup Akouos... Read more »
Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company of more than 60 years.
Greenfield, IN-based... Read more »
Thomas Hughes is leaving Zafgen, which he led for nine years, in order to take the top job at another biotech company.
The job change comes 10 months after Hughes resigned... Read more »
Verana Health, a company that analyzes electronic health record data for insights useful in developing new drugs and medical devices, has raised $30 million in financing.
GV, the venture arm of... Read more »
Orexigen Therapeutics went bankrupt trying to turn its weight loss pill, Contrave, into a commercial success. Now Pernix Therapeutics will try its luck.
Pernix (NASDAQ: PTX) said Monday that a... Read more »
[Story updated 7/27/18, 7:07 p.m. EDT. See below.] The runup to a new drug launch is usually a time for hiring, but as Achaogen commercializes its new drug, the... Read more »
Data from six additional months of treatment with an experimental drug for Alzheimer’s disease were enough to turn a failed mid-stage clinical trial into a possible success. On Wednesday, the Japanese... Read more »
Cool Planet, an agricultural technology startup focused on improving the quality of soil, has raised an additional $20.3 million to finance construction of a manufacturing facility.
Greenwood Village, CO-based Cool Planet... Read more »
Nabriva Therapeutics has acquired Zavante Therapeutics in a stock deal that brings to the antibiotics developer an FDA-ready drug.
Under the deal terms announced after the market close Tuesday, San Diego-based... Read more »
An Agios Pharmaceuticals drug developed to treat a rare form of leukemia has received FDA approval ahead of schedule. This marks the second time in the past year that the company... Read more »
PTC Therapeutics is looking to gene therapy in a bid to broaden its pipeline, scooping up privately held Agilis Biotherapeutics in a cash and stock deal.
South Plainfield, NJ-based PTC... Read more »
[Updated, 7/19/18, 6:25 p.m. See below.] A patient has died in a clinical trial testing Mersana Therapeutics’ lead cancer drug, and the FDA has put a partial hold on... Read more »
Nearly one year ago, biotech startup IFM Therapeutics sold some of its assets to Bristol-Myers Squibb for $300 million. But IFM’s founders stuck around to try to capitalize on the startup’s... Read more »
Rubius Therapeutics has joined the parade of biotech companies going public, raising a whopping $241.1 million to support its approach of engineering red blood cells into off-the-shelf treatments for disease.
Late... Read more »
The seeds farmers plant in their fields can carry certain desirable traits, such as drought tolerance or pest resistance. Breeding or genetic engineering can produce such traits, but ag biotech startup... Read more »
In real estate, location is key. The same holds true in the hunt for new drugs. HotSpot Therapeutics is trying to break new ground in drug discovery by hitting locations on... Read more »
The cause of fibrosis, the hardening and thickening of connective tissue in organs, isn’t known and it has few treatments. Pliant Therapeutics aims to bring patients who have this chronic and... Read more »
More than a year after the FDA rejected Amgen’s experimental osteoporosis drug due to safety concerns, the Thousand Oaks, CA, company has teed up a new application.
The Amgen (NASDAQ:... Read more »